12435713 CANADA LTD.
$30,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- August 7, 2023 – March 31, 2024
- Reference
- nrc-cnrc:172-2023-2024-Q2-1008494
Published purpose
GFR90 is developing and commercializing a wearable artificial kidney used for ambulatory dialysis. Hemo-dialysis used for end stage renal disease is effective - but only when it is being used. The intermittency of dialysis creates social, economic, and medical issues. Our device allows fluid and toxin extraction (i.e., urine) on a near-continuous basis, like a healthy kidney. The device in its current iteration is 6 lbs, in vest form, and can be worn at virtually any time and during most activities during the day. The effect of this is to remove the intermittency of in-clinic dialysis and allow near-continuous, in-home dialysis which can correct the issues with in-clinic intermittency.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.